Genetic Maps Target Root Causes of Multiple Sclerosis

Key Points:

• A new study from the University of Notre Dame provides the first direct, empirical comparison of the two leading preclinical mouse models for multiple sclerosis (MS) research—cuprizone (CPZ) and lysophosphatidylcholine (LPC)—highlighting their distinct mechanisms and timelines of demyelination.
• CPZ induces widespread, gradual myelin loss over weeks, making it better suited for studying myelin-producing cell stress, death, and repair, while LPC causes rapid, localized lesions ideal for investigating acute immune responses.
• Using single-cell RNA sequencing, researchers mapped genetic changes in both models and matched them to human MS tissue, ensuring clinical relevance and revealing unique gene expression patterns that may influence myelin regeneration.
• The findings emphasize that these models are not interchangeable and provide a scientific roadmap to guide researchers in selecting the appropriate model to target different aspects of MS pathology for drug development.
• Current MS treatments focus mainly on suppressing autoimmune attacks, but this study underscores the need to develop therapies aimed at physically regenerating lost myelin, a promising yet unrealized therapeutic frontier.